BRANFORD, CT – October 16, 2026 (STL.News) Azitra Inc. (NYSE American: AZTR), a clinical-stage biotechnology company developing treatments for dermatological conditions, announced Friday that it will implement a 1-for-10 reverse stock split, reducing its issued common shares from approximately 60.6 million to 6.06 million. The transaction is scheduled to become effective at 12:01 a.m. Eastern Time on October 26, 2026. Azitra shares will begin trading on a split-adjusted basis when the NYSE American opens that morning, retaining the existing ticker symbol AZTR. The decision represents a significant change in the company’s capital structure. Although the transaction will reduce the
Source: Read Original Article
